A Study of CS3006 in Subjects with Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT03516123 · COMPLETED

Trial details

NCT number: NCT03516123
Sponsor: CStone Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2018-06-14
Primary completion: 2020-06-18
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.